GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Accounts Payable & Accrued Expense : ₦20,146 Mil (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Accounts Payable & Accrued Expense?

GlaxoSmithKline Consumer Nigeria's quarterly accounts payable & accrued expense increased from Sep. 2022 (₦17,849 Mil) to Dec. 2022 (₦18,470 Mil) and increased from Dec. 2022 (₦18,470 Mil) to Jun. 2023 (₦20,146 Mil).

GlaxoSmithKline Consumer Nigeria's annual accounts payable & accrued expense increased from Dec. 2020 (₦14,363 Mil) to Dec. 2021 (₦15,011 Mil) and increased from Dec. 2021 (₦15,011 Mil) to Dec. 2022 (₦18,470 Mil).

GlaxoSmithKline Consumer Nigeria Accounts Payable & Accrued Expense Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Accounts Payable & Accrued Expense Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

5,066.31

7,728.92

14,362.57

15,010.54

18,469.96

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															14,998.36	15,078.19	17,849.07	18,469.96	20,145.56

GlaxoSmithKline Consumer Nigeria Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines